These results confirmed that the CD133+ subpopulation displayed CSCs features, consistent with previous studies [18].In this study, we designated CD133+ cell fractions as pancreatic cancer stem-like cells whereas CD133− cell fraction utilized as non-stem cells. The gene discussed is PROM1; the disease is pancreatic neoplasm.